BRASILIA | brazil’s ministry of Health announced on Monday that it would maintain its recommendation of using hydroxychloroquine to treat the coronavirus, despite the decision of the world health Organization (WHO), to temporarily suspend the clinical trials with this drug as a precautionary measure.
“We remain very calm and serene, and there will be no change” in our instructions, said Mayra Pinheiro, secretary of labor management and health education, during a press conference in Brasilia.
Under pressure from the president, Jair Bolsonaro, the ministry of Health of Brazil, the country most severely affected by the coronavirus in Latin America, has published last week a document that extended the recommendations for use of chloroquine and hydroxychloroquine, including mild cases of Covid-19 despite the lack of conclusive evidence of its effectiveness.
This decision has triggered a wave of criticism in the scientific community, brazilian.
The WHO announced on Monday that it had suspended “temporarily” clinical trials with hydroxychloroquine it has with its partners in several countries, as a precautionary measure.
This decision taken on Saturday following the publication of a study the day before in the medical journal The Lancet holding ineffective, or even harmful, the use of chloroquine or its derivatives such as hydroxychloroquine against the Covid-19, indicated the director-general of WHO, Tedros Adhanom Ghebreyesus.
With more than 363 200 cases and more than 22 660 deaths, according to the latest balance sheets, officials, Brazil (210 million inhabitants) is the most affected country by the pandemic in Latin America and the second largest in the world behind the United States in the number of confirmed cases.